Baxter International | BAX - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Abbott USD 18.38B 1.88B 2026-03
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Avanos Medical USD 131.2M 34M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Fresenius EUR 8.38B 1.18B 2025-12
Globus Medical USD 482.46M 16.04M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
ICU Medical USD 517.9M 19.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Masimo USD 325.4M 46.2M 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Smith & Nephew USD 1.54B 236M 2025-12
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Terumo JPY 540.73B 1.03B 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03